Circio Holding (”Circio” or ”the Company”) announced, on the 30th of January 2026, the final outcome of the rights issue, which attracted subscriptions of approx. NOK 77.9m, corresponding to a subscription of 156% relative to the targeted NOK 50m. As approved by the extraordinary general meeting on the 12th of January 2026, Circio will also carry out a parallel private placement of approx. NOK 15m to accommodate oversubscription of the rights issue. This brings total gross proceeds from the transactions to approx. NOK 65m, compared with the initially targeted NOK 50m. The capital injection from the rights issue and the parallel private placement is estimated to provide a cash runway until Q1-27. Including the potential exercise of the attached warrants in Q2-26, Circio is estimated to have sufficient capital to fund operations into early Q1-28.

In summary,Analyst Group believes that the oversubscribed rights issue meaningfully improves Circio’s financial position and enables continued execution on the Company’s preclinical development strategy. With funding estimated into Q1-28, based on a conservative assumption of warrant exercise in Q2-26 at a strike price derived from the rights issue subscription price (NOK 1.0 per share), the Company is well positioned to fund the upcoming acceleration of circVec R&D activities and strengthen the scientific team in Stockholm. With key de-risking events such as active T-cell targeting data expected in Q2-26, as well as the generation of in vivo CNS PoC data linked to the ongoing partnership with a major pharmaceutical company and disease-model efficacy data in eye and heart indications expected in H2-26, Circio has a pipeline of upcoming value-inflecting milestones that could act as catalysts for increased licensing partner interest and the valuation of the Company.

Read Analyst Group’s comment here

About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group

This is a press release from Analyst Group regarding the publication of a comment on Circio Holding. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.

Läs mer på MFN